Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Scope of the Report:
The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary Autotransfusion systems market in the Americas during the forecast period.
Cardiac surgeries are complex and may result in a significant loss of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for significant volumes of blood supply, which depends on the complexity of the surgery.
The worldwide market for Cardiopulmonary Autotransfusion System is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 590 million US$ in 2024, from 510 million US$ in 2019, according to a new study.
This report focuses on the Cardiopulmonary Autotransfusion System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Unwashed ATS
Washed ATS
Market Segment by Applications, can be divided into
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiopulmonary Autotransfusion System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cardiopulmonary Autotransfusion System, with price, sales, revenue and global market share of Cardiopulmonary Autotransfusion System in 2017 and 2018.
Chapter 3, the Cardiopulmonary Autotransfusion System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiopulmonary Autotransfusion System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cardiopulmonary Autotransfusion System market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cardiopulmonary Autotransfusion System sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Scope of the Report:
The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary Autotransfusion systems market in the Americas during the forecast period.
Cardiac surgeries are complex and may result in a significant loss of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for significant volumes of blood supply, which depends on the complexity of the surgery.
The worldwide market for Cardiopulmonary Autotransfusion System is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 590 million US$ in 2024, from 510 million US$ in 2019, according to a new study.
This report focuses on the Cardiopulmonary Autotransfusion System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Unwashed ATS
Washed ATS
Market Segment by Applications, can be divided into
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiopulmonary Autotransfusion System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cardiopulmonary Autotransfusion System, with price, sales, revenue and global market share of Cardiopulmonary Autotransfusion System in 2017 and 2018.
Chapter 3, the Cardiopulmonary Autotransfusion System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiopulmonary Autotransfusion System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cardiopulmonary Autotransfusion System market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cardiopulmonary Autotransfusion System sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
